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Abstract
The folding mechanism of integral membrane proteins has eluded detailed study, largely as a result of the inherent
difficulties in folding these proteins in vitro. The seven-transmembrane helical protein bacteriorhodopsin has, however,
allowed major advances to be made, not just on the folding of this particular protein, but also on the factors governing
folding of transmembrane K-helical proteins in general. This review focusses on kinetic and equilibrium studies of
bacteriorhodopsin folding in vitro. It covers what is currently known about secondary and tertiary structure formation as
well as the events accompanying retinal binding, for protein in detergent and lipid systems, including native membrane
samples. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The folding of bacteriorhodopsin (bR) has been
the most widely studied of any membrane protein.
Much of this is thanks to the remarkable feats of two
groups in the 1970s that placed folding studies of bR
in a unique position: not only can aspects of its
folding from a denatured state be studied in vitro
in a variety of detergents and lipids, but also several
important folding events can be followed in a native
membrane environment. Following on from their
successful isolation of bacteriorhodopsin [1,2] Oester-
helt, Stoeckenius and co-workers went on to show
that binding of the retinal cofactor in a native purple
membrane (PM) environment was reversible [3].
Since then, these workers have produced a sequence
of detailed studies on this retinal binding event and
the associated protein structural changes (for exam-
ple [4^7] [8] and see a recent review [9]). Meanwhile
Khorana and coworkers used bacteriorhodopsin to
demonstrate for the ¢rst time that a membrane pro-
tein could be refolded from a denatured state in vitro
[10,11]. Their approach proved to be invaluable in
obtaining high yields of overexpressed protein from
Escherichia coli [12]. Nearly every amino acid in the
protein has been individually mutated and the e¡ect
on the generation and the function of the folded state
investigated (for example see [13^18]). Several crystal
structures have been reported for bR recently, the
highest resolution being 1.55 Aî [19] (see also [20]
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and minireviews by E. Landau and H. Luecke in this
issue).
2. How can bR be denatured and refolded in vitro?
Denaturants that destroy the structure of most
water-soluble proteins have nowhere near the same
e¡ect on bR. For example, even completely delipid-
ated apoprotein (bacterio-opsin, bO) is resistant to
denaturation by 8 M guanidinium chloride [10]. Tri-
£uoroethanoic acid or 88% methanoic acid have to
be used to completely denature the delipidated pro-
tein to a random coil-like state. Such drastic dena-
turants have also been found to be e¡ective at un-
folding transmembrane helices of other membrane
proteins. Refolding bR has of course to be achieved
in detergents or lipids (in the presence of retinal). A
problem arises in transferring the organic acid-dena-
tured state to this refolding environment, as the or-
ganic acid will destabilise the detergent or lipid moi-
eties. It is possible to transfer the acid-denatured bO
state initially into SDS by neutralising the acid and
dialysing against this detergent [10]. The SDS state
remains denatured from the point of view that it
cannot bind retinal, but it acquires K-helical struc-
ture equivalent to almost 4 transmembrane helices
[11,21]. The protein can then be transferred into a
variety of renaturing detergent micelles, mixed deter-
gent/lipid micelles or lipid vesicles, by diluting or
precipitating the SDS [10,11,22^24]. bR spontane-
ously refolds under these conditions in the presence
of retinal. Refolding yields of about 95% can be
readily obtained, for example in mixed DMPC/
CHAPS micelles [24], DMPC/DHPC micelles [25],
native lipid vesicles [23], DPoPC vesicles [26] and
DMPC vesicles [23,26]. SDS can be omitted from
the unfolding/refolding process by co-dissolving deli-
pidated bO and lipids in organic solvent, drying o¡
the solvent and re-dissolving the bO/lipid mixture.
bR can then be regenerated by the addition of retinal
and again yields of about 85% can be achieved (W.
Meijberg, A.R. Curran, R.H Templer and P.J.
Booth, unpublished data).
The refolding yields are generally determined from
the extent of recovery of a native-like, purple chro-
mophore absorption band at about 560 nm [11,27].
The pKa of the covalent Schi¡ base (SB) linkage
between retinal and Lys-216 in the refolded protein
is 11.8 [28], which is close to that of PM which has a
SB pKa of 13.3 [29]. The refolded bR is monomeric
and shows native-like activity. The formation and
decay of the M intermediate, which is a key step in
the proton-pumping photocycle, exhibit similar char-
acteristics to wild-type protein. Proton pumping has
also been demonstrated for refolded bR in DMPC/
CHAPS micelles [30]. The photocycle kinetics of re-
folded monomeric bR, as well as that isolated from
PM, are dependent on the detergent/lipid environ-
ment. Thus, whilst over 95% of the refolded bR
has native-like activity, the actual ‘folded state’ of
the protein has slight conformational di¡erences in
di¡erent refolding environments. This probably re-
£ects a change in the distribution of thermally acces-
sible folded conformations with the detergent/lipid
environment.
3. An in vitro folding mechanism
The refolding kinetics of SDS-denatured bO in
DMPC/CHAPS, DMPC/DHPC micelles and DPoPC
vesicles, in the presence of all-trans retinal, have been
investigated by time-resolved £uorescence and ab-
sorption spectroscopy. The protein spontaneously re-
folds on diluting the SDS with the renaturing mi-
celles or vesicles [31]. Stopped-£ow mixing of the
SDS and renaturing micelles occurs with a time con-
stant of about 4 ms. The simplest reaction scheme





bO is the SDS denatured state and I1 and I2 are
intermediates that form prior to retinal binding. Ret-
inal, R, binds in at least two steps, ¢rst non-cova-
lently to give IR and secondly via the covalent link to
Lys-216 to give bR. IR probably consists of at least
two observable states (see below), one where the ret-
inal absorption band is similar to that of free retinal
at about 380 nm (IR380) and one where the retinal
band is red-shifted to 440 nm (IR440). Both bO and I2
also probably possess equivalent, additional states,
although they have not been observed.
The intermediate I1 could either be an apoprotein
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folding intermediate or re£ect a change in the mi-
celle/vesicle structure as a result of stopped £ow mix-
ing. A change in protein £uorescence occurs during
I1 formation with a time constant, d1, of the order of
hundreds of milliseconds in micelles. However there
is also a change in the micelle structure which occurs
with the same observed time constant, d1, and is
accompanied by an increase in the amount of light
scattered by the micelles [32]. Thus d1 may not be a
bona ¢de folding event, but rather re£ect the micelle
structural change, which alters either the hydropho-
bic environment of the protein tryptophans and/or
the apparent protein conformation. The change in
protein £uorescence with time constant, d1 is lost
when arginine at position 175 is mutated to gluta-
mine [31]. Arg-175 has been suggested to be involved
in correct tilting and orientation of some transmem-
brane helices in PM, through an interaction of its
positive charge with the lipid headgroups [33]. Thus
I1 formation could be a folding event which involves
helix orientation. Alternatively, it is conceivable that
the micellar structural change that occurs during I1
formation, alters the interaction between Arg-175
and the detergent/lipid headgroups, and as a result
no change in protein £uorescence is seen with this
time constant in the Arg175Gln mutant.
All the kinetic folding experiments thus far point
to the apoprotein intermediate I2 being key to the
folding process and a pre-requisite for retinal bind-
ing. Formation of I2 is rate-limiting in apoprotein
folding. The rate of this step can be controlled by
manipulating particular characteristics of the refold-
ing lipid environment, with the time constant ranging
from 1 s to minutes (see below). Changes in intrinsic
protein £uorescence also suggest the process is bi-
exponential under certain lipid conditions, which
probably re£ects folding of slightly di¡erent confor-
mations of the protein. The changes in protein sec-
ondary structure have been time-resolved during this
stage of folding by far UV circular dichroism (CD)
[21]. The SDS-denatured bO state has an K-helical
content of about four TM helices, whilst the remain-
ing equivalent of three TM helices are disordered.
The secondary structure of I2 is native-like and cor-
responds to seven TM helices. About half of the
disordered SDS structure folds to form helices during
the 20 s deadtime of these particular far UV CD
experiments, whilst the remaining 30 or so amino
acids form helices with a time constant equivalent
to I2 formation. The extent and nature of the tertiary
interactions in I2 are unknown. A possible model for
the protein structural changes that occur during I2
formation is shown in Fig. 1. This is largely based on
a two-stage model that has been proposed for the
folding of K-helical membrane proteins as well as
indirect evidence form studies on helical fragments
of bR, the time-resolved CD studies and the lipid
dependence of the folding kinetics (see below).
Only one retinal-binding step has been identi¢ed in
folding of bR in mixed micelle systems, when retinal
binds non-covalently to I2, probably within some
sort of loosely formed binding pocket [27]. Although
Fig. 1. A possible model for the folding of bacterio-opsin prior to the binding of retinal. Five TM helices, A^E, fold and partially
pack, according to the two-stage model. Formation of this ¢ve-helical state then induces insertion and folding of the remaining two
helices F and G. The resulting seven TM state has a loosely packed structure. The ¢nal helix packing and tertiary contacts form as
the protein folds round retinal.
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this bi-molecular retinal binding reaction strictly fol-
lows second-order kinetics, for convenience it can be
approximated to one or two exponential functions
with time constants of about 1 s. Studies of this
retinal binding process are complicated by the pre-
ceding formation of I2. However, the binding reac-
tion can be more readily investigated by allowing bO
to prefold to a state equivalent to I2 and then adding
retinal [24]. There appear to be at least two non-co-
valent, retinal, protein IR states. One retinal, protein
intermediate (IR440) is observed in transient absorp-
tion measurements because the retinal absorption
band red shifts from 380 to 440 nm. This intermedi-
ate corresponds to a non-covalently bound state seen
in studies of retinal binding to apomembrane (see
below). However the formation of IR440 alone cannot
account for the observed retinal, protein concentra-
tion dependence of the kinetics [64]. Another inter-
mediate IR380 is suggested to form and decay in par-
allel with IR440 and with the same observed kinetics.
This could result from a distribution of protein con-
formers in I2 that have slightly di¡erent protonation
equilibria of their side chains and can interconvert by
thermal energy. Retinal binding to these I2 conform-
ers occurs via the same transition state (or distribu-
tion of interconverting transition states on a micro-
scopic scale) to form IR. IR also contains a similar
distribution of protein conformers as I2, however the
di¡erent protonation equilibria of the protein confor-
mations a¡ect the retinal absorption band and thus
show up in this retinal bound state. IR440 and IR380
both decay with the same observed time constant of
a few minutes to form refolded bR with a 560nm
absorption band where the SB bond has formed
and retinal is covalently bound. This bR state con-
tains all-trans retinal within its binding pocket. The
retinal then isomerises on a much slower time scale
(time constant about 1 h) to a state equivalent to the
dark-adapted state of bR that contains a mixture of
all-trans and 13-cis retinal.
4. Transmembrane K-helix insertion, formation and
the two-stage folding model
Experiments on bR are at the root of a ‘two-stage’
model that has been proposed for the folding of K-
helical membrane proteins [34]. This model proposes
that insertion and formation of transmembrane heli-
ces occurs as a ¢rst stage in folding, as these helices
are independently stable entities within the mem-
brane. Stage two then involves the correct packing
of these helical segments to give the folded structure.
Whilst this model does not necessarily re£ect how
membrane proteins actually fold in vivo, nor gives
any prediction of the in vivo or in vitro folding
mechanism, it does provide a thermodynamic base
from which to consider the problem. Key features
of the two-stage model have been tested with bR.
Stage one predicts that each individual TM helix of
bR ought to be independently stable in a lipid bi-
layer. Peptides corresponding to each of the inde-
pendent helices have been synthesised and their pro-
pensity to form a stable transmembrane helix
assessed [35]. As predicted, ¢ve of the peptides can
form stable TM helices in bilayer vesicles of native
lipids. However, a peripheral, membrane-bound con-
formation containing some K/L-structure was pre-
ferred by the peptide corresponding to helix F, and
that for helix G formed a L-sheet structure within the
membrane.
Studies on TM fragments of bR began with the
enzymatic cleavage of the BC loop to give two frag-
ments consisting of the AB and C^G helices, respec-
tively [10,22,34]. Both fragments form structures in
DMPC/CHAPS micelles and native lipid or DMPC
vesicles with the expected two TM or ¢ve TM helix
content. The fragments are also able to re-associate
and bind retinal to form functional protein. A recent
extension of this approach has involved the overex-
pression of all two to ¢ve helix fragments of the
protein [28]. Far UV CD studies show that the indi-
vidual N terminal fragments, AB, A^C, A^D, A^E
as well as that of C^G, have helix contents in
DMPC/DHPC micelles that are equivalent to the
corresponding regions of the native folded protein
[36]. However the remaining C terminal fragments
D^G, E^G, FG as well as the CD, C^E and DE
fragments have lower helix contents at pH 6 than
expected if they were in a folded state, and indeed
the FG fragment has about 20% L structure. All
pairs of complementary fragments (ABWC^G, A^
CWD^G, A^DWE^G, A^EWFG) assemble in DMPC/
CHAPS micelles in the presence of retinal to form
functional protein with native-like K-helical content.
Thus some of the C-terminal fragments misfold or
BBABIO 44881 18-8-00
P.J. Booth / Biochimica et Biophysica Acta 1460 (2000) 4^14 7
only partially fold on their own, whilst the N-termi-
nal fragments each fold to attain their correct helical
structure. The correct secondary structure of the C-
terminal fragments is then induced by their interac-
tion with their complementary N-terminal fragments
and retinal.
The studies on bR fragments also go some way to
answer a key question of the second stage of the two-
stage model; can preformed, individual transmem-
brane helices pack correctly to form the functional
state? The answer for helices A^E seems to be yes. It
is harder to tell for F and G, because individually
they do not form independently stable TM helices.
Furthermore all C-terminal fragments with four or
fewer TM helices do not fold to give the expected
TM helix content.
On the basis of these studies, some slight re¢ne-
ments of the two stage model can be proposed [35].
The ¢ve N-terminal helices of bR seem to be able to
fold according to the two-stage model. The remain-
ing two C-terminal helices do not form stable TM
helices on their own, and are probably stabilised in
their folded TM helical state by interaction with the
previously formed ¢ve helix bundle (see also Fig. 1).
Therefore, it does not appear to be necessary for
each individual TM helix of a membrane protein to
be a stable entity in the absence of the rest of the
protein. Only a certain proportion of the TM helices
need exhibit such stability, which in the case of bR
appears to be ¢ve out of its seven helices. This could
leave room for the remaining helices to forego TM
stability in favour of including amino acids that
could be important for function or other stages of
folding, such as helix association.
Correct helix packing and retinal binding are crit-
ical to the formation of a functional state of bR. The
in vitro kinetic work suggests that retinal binds to a
partially folded apoprotein state, I2 that has some of
the binding pocket already present, but it is un-
known exactly how retinal gains access. It is also
unknown what correct tertiary contacts between the
helices are present in this I2 state, as well as what
controls the speci¢c packing of the helices during
folding. There are probably some speci¢c helix^helix
contact sites present in the partially folded state I2.
Retinal binding to I2 would then allow the helices to
pack round the bound retinal to form the folded
state. The aqueous loops that connect the helices
could also help to provide some speci¢city and close
packing. However that fact that all the helix frag-
ments discussed above can form a functional protein
with breaks in the loops, shows that no individual
loop is essential for correct folding of the protein.
Mutations of each loop in turn to structureless link-
ers also results in a functional protein with only
fairly subtle changes in the folding kinetics (J.-M.
Kim, H.G. Khorana, S.J. Allen, H. Lu, P.J. Booth,
unpublished data). Changes or cleavage in the BC
loop, which seems to have some L-structure [37],
can lead to a blue shifted chromophore [14,22].
Although this is temperature-dependent and under
certain conditions it is possible to attain the purple
chromophore for protein with a break in this loop,
either generated from fragments expressed in E. coli
[28] or by cleavage of native protein [23]. The recent
high resolution crystal structures of bR [19,38] have
also revealed hydrogen bonding between neighbour-
ing helices, both between side chains and main chain
to side chain bonds. The strength of such bonds
within the bilayer presumably contributes to the
stability of the folded state and could aid correct
helix packing. On the other hand, they may hinder
folding if non-native hydrogen bonds form en route.
Bacteriorhodopsin is remarkably tolerant of
changes in its amino acid sequence [16]. Many single
point mutations, as well as the changes in the loops
discussed above, have been studied using the E. coli
expression system with a synthetic bO bop gene, and
then folding the protein from its SDS-denatured
state. These studies have shown that in vitro many
of the mutant proteins are capable of folding to a
functional state with a native-like purple absorption
band (see Fig. 2). Some of the mutants have also
been studied following homologous expression in
Halobacterium salinarium, where they are also able
to fold to a bR-like state, although di¡erent pheno-
types and chromophore bands have been observed.
The overall folding rate of the mutants expressed in
E. coli has been determined in mixed DMPC/CHAPS
micelles and generally they fold only slightly slower
than wild-type. The detailed folding kinetics in
DMPC/CHAPS micelles have only been studied for
a few mutant proteins. Thus, for example, single
point mutations of the charged amino acids arginine
and aspartic acid to glutamine and asparagine, re-
spectively, near the helix ends and in the helix-con-
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necting loops have little a¡ect on folding. In each
case, the kinetics of apoprotein folding to I2, retinal
binding to form IR and overall bR formation are
similar to wild-type protein (P.J. Booth, S.L. Flitsch,
H.G. Khorana, unpublished data) [39]. This is per-
haps not surprising in view of the fact that no indi-
vidual loop seems necessary for correct folding (see
above). Protein with single point mutations of
Ser183Ala, Tyr185Phe, Ser193Ala and Glu194Gln
on helix F also all fold to functional states with
native-like bound chromophores, but with slower
overall folding rates. Some single point mutations
have greater e¡ects on bR folding, as shown by other
single point mutations on helix F of Arg-175, Trp-
182, Pro-186, Trp-189. For example, Arg175Gln
folds to a native-like state about ten times slower
than wild-type [40] and has altered early apoprotein
kinetics that result in the loss of the kinetic phase d1,
which is associated with formation of the intermedi-
ate I1 (P.J. Booth, S.L. Flitsch, H.G. Khorana, un-
published data). Mutations of amino acids that line
the retinal binding pocket can lead to blue shifts in
the bound chromophore absorption band (e.g.
Trp86Phe, Trp182Phe, Trp189Phe, Pro186Gly/Val/
Leu [18] [41]). In contrast, some mutations of Asp
acids 212 and 85, which are involved in proton
pumping give rise to red shifts in the bound chromo-
phore absorption band (Asp212Glu, Asp85Glu,As-
p85Asn) [39]. Although Asp212Asn has an unshifted,
wild-type-like chromophore. The Asp mutations, to-
gether with Pro186Gly show more or less wild-type
apoprotein folding kinetics to I2, but altered retinal
binding (H. Lu, T. Marti, P.J. Booth, S.L. Flitsch,
H.G. Khorana, unpublished data). The molecular
origin of these various shifts in the bound chromo-
phore band of the mutants as compared to wild-type
is unknown. They could re£ect slight di¡erences in
the folded structure to wild-type, which results in a
modi¢ed retinal binding pocket, or an altered elec-
trostatic environment of the bound retinal. In certain
cases (e.g. Pro186Gly) they may re£ect two bound
species, possibly in equilibrium, one of which is the
normal purple chromophore. The blue shifted chro-
mophore of Pro186Gly can be converted to the nor-
mal purple species at high salt. Thus di¡erent folding
conditions may well alter the observed chromophore
band(s), but this has not been investigated in detail
in many cases. Altered chromophore absorption
bands have also been observed in certain cases
when the mutants are expressed in H. salinarium.
For example, Asp212Asn has a wild-type chromo-
phore when expressed from E. coli, but a red shifted
chromophore when expressed in H. salinarium [42].
Trp182Phe from E. coli has a blue-shifted band,
but has been reported as unshifted when homolo-
gously expressed [43]. These homologous expres-
sions use a bacterial strain where the wild-type bop
gene is present in an inactive form, together with
the mutant bop gene, although recombination fre-
quencies between the two genes seem to be su⁄-
ciently low that the mutant phenotype dominates.
The position of the chromophore band in purple
membrane is also dependent on ionic strength and
pH [44].
Lys-216 has also been mutated to investigate the
e¡ect of the covalent link to retinal on the folding
and function of the protein. Studies on a Lys216Ala
mutant expressed in H. salinarium and then reconsti-
tuted with retinylidene alkylamines show that bR can
function with these retinylidene SB compounds, but
without the covalent link to Lys-216 [7]. Kinetic
studies on Lys216Cys in DMPC/CHAPS micelles
show that this protein has altered folding kinetics
to I2, but wild-type retinal binding to give a non-
covalently bound intermediate state, IR440 with an
Fig. 2. A representation of the secondary structure of bR, high-
lighting some of the sites of mutations referred to in the text.
E, Site of mutation that has so far been found to have little ef-
fect on folding; a, Site of mutation that has a greater e¡ect on
folding.
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absorption maximum at 440 nm (H. Lu, P.J. Booth,
S.L. Flitsch, H.G. Khorana, unpublished data).
Bacteriorhodopsin, like many membrane proteins,
has proline residues near the middle of transmem-
brane helices. This is unexpected in view of the large
body of data that exists on water soluble proteins
which indicates that Pro is a helix breaker that is
rarely found at the centre of helices [45,46]. Prolines
are unique amongst amino acids in that a cis as well
as trans arrangements of the peptide bond can read-
ily occur, especially in unfolded states. Studies of
water soluble proteins have shown that isomerisation
of non-native (generally cis) prolines to the native
isomer is frequently rate-limiting in folding and oc-
curs with a time constant of the order of seconds.
Although there have been no studies on cis^trans
proline isomerisation during membrane protein fold-
ing, cis-trans isomerisations of the transmembrane or
the loop prolines of bR could be the origin of some
of the kinetics that have been observed. The isomer-
isation state of the prolines in the SDS-denatured bO
state is unknown, but they are all trans in folded bR
[19]. The three transmembrane prolines of bR have
been mutated to both Gly and Ala and their overall
folding from an SDS-denatured state to a folded
state assayed in DMPC/CHAPS micelles [41]. The
mutations of Pro-50 and Pro-91, which are on helices
B and C, respectively, resulted in normal purple
chromophore formation and protein activity. The
overall folding rates were slower than those of
wild-type, except for Pro50Gly that folded faster.
Pro-186 lies on helix F and seems to form a very
close contact with the retinal. Mutation of Pro-186
to Gly resulted in a blue-shifted chromophore band.
Thus these transmembrane prolines, and particularly
Pro-50 and Pro-186 do contribute to the folding of
bR, and more detailed studies of this are underway.
5. Folding and reconstitution in a native membrane
environment
Folding studies in a more native-like environment
have been tackled in three main ways. Two ap-
proaches have covered detailed biophysical studies
on retinal binding to apomembrane. This apomem-
brane state is formed either by bleaching PM or from
a retinal de¢cient bacterial strain. The apomembrane
contains bO that is probably arranged in trimers, but
lacks the characteristic crystalline array of PM. For-
mation of PM is then achieved either by addition of
all-trans retinal to the apomembrane, or by photo-
isomerisation of 9-cis retinal already non-covalently
bound to the apomembrane. This 9-cis isomer cannot
bind to give functional protein, but the formation of
PM is triggered by the photoisomerisation to all-
trans retinal that does bind to give a functional state.
The third native membrane approach has been to
study the formation of the PM crystalline lattice in
vivo by investigating the e¡ect of mutations ex-
pressed in H. salinarium, where the wild-type bop
gene has been deleted and completely replaced by
the mutant gene ([47,48] and see minireview by MP
Krebs in this issue).
The apomembrane studies show that all-trans ret-
inal binds in two stages to form PM [4,5,49]. Firstly
retinal is ¢xed within its binding site and ring-chain
planarisation of the molecule occurs, resulting in a
red shift of the retinal absorption band from about
380 to about 400 nm. A further red shift of the
absorption band is then observed giving an inter-
mediate with an absorption band with maxima at
430 and 460 nm. Retinal is non-covalently bound
within its binding pocket in both the 400 and 430/
460 nm states. Finally, the covalent SB forms and the
characteristic 560 nm purple band is observed. The
protein secondary structure in the apomembrane and
PM states appears to be the same. The tertiary struc-
tures of the apomembrane state has not been inves-
tigated in detail, but signi¢cant tilting of the helices
from the membrane normal has been noted in this
state [50]. The photoisomerisation of 9-cis retinal as
a trigger of PM formation has allowed the secondary
structure and side chain protonation changes that
occur during these retinal binding reactions to be
probed by FTIR di¡erence spectroscopy [6,51]. Pro-
tonation changes were observed with pKa shifts for
two apparent proton-binding groups from pKa’s of
4.6 and 7.1 in the apomembrane state to 2.8 and 8.9,
respectively, in purple membrane. These proton
binding groups could not be assigned to particular
amino acids and were suggested to result from a
hydrogen-bonded network in the protein (possibly
involving E204, D85, R82, and Y57 and bound
water) that is capable of binding two protons. Evi-
dence for the participation of water in SB formation
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has also been found in studies of bR at di¡erent
humidities [52,53]. The pKa of the PM SB also varies
with conditions. The SB of native PM has a high pKa
of about 13. In contrast, lower pKa values of 9 or 8.5
have been found for PM that has been generated by
addition of retinal to apomembrane, prepared from
bleaching PM or from retinal-de¢cient cells, respec-
tively [8]. In the latter case, a higher pKa of s 10 was
found for the in vivo formation of PM, when retinal
was added to the retinal-de¢cient cells during cell
growth. This was suggested to re£ect a di¡erent
packing of the helices in the apomembrane state as
compared to PM, and may be connected with the
lack of the crystalline array of bR in the apomem-
brane state. Thus when retinal is present during syn-
thesis of the PM the helices can fold more tightly
round the retinal than when retinal is added to apo-
membrane after cell growth and apomembrane iso-
lation. When monomeric bR is formed by addition
of retinal to SDS-denatured apoprotein in DMPC/
CHAPS micelles, the resulting pKa of the SB is about
11.5 [28]. This suggests that the intermediate state I2
that retinal binds to in the micelles may be less com-
pact with fewer tertiary interactions than the apo-
membrane state. A less compact state could arise
as a result of the higher detergent/lipid:protein ratio
in DMPC/CHAPS micelles. Thus, in the micelle sys-
tem, the protein folds more tightly around retinal,
resulting in a high pKa, as observed when retinal is
present during PM synthesis in vivo.
What are the parallels between the refolding of
monomeric bR and reconstitution in the membrane?
The folding events accompanying retinal binding ap-
pear to be very similar in the two instances. Retinal
binds ¢rst non-covalently in its binding pocket, re-
sulting in an observed absorption shift of retinal to
about 440 nm. The ¢nal step is then covalent binding
of retinal and formation of the 560 nm chromo-
phore. The pH dependence of the refolding kinetics
of monomers in DMPC/DHPC micelles also agree
with the FTIR studies on retinal binding to apomem-
brane, and are consistent with a change in the pKa of
two apparent proton-binding groups. The pKa of the
SB seems to depend on the refolding/reconstitution
conditions. Refolding in DMPC/CHAPS micelles
gives pKa of over 11, as in native PM, whereas addi-
tion of retinal to apomembrane results in a lower
pKa of about 8^9, unless retinal is present during
cell growth and PM synthesis. The state to which
retinal binds is similar in both apomembrane and
micellar samples to the extent that all seven TM
helices are present. However, these two apoprotein
states could di¡er in terms of their helix packing. The
monomeric micelle state may be rather more un-
folded and then packs tightly round the retinal,
whilst the apomembrane state has a loosely packed,
but stable structure that does not rearrange as much
as retinal binds.
Very little is known about the mechanism of bR
insertion and folding in vivo. A recent kinetic assay
has been reported for this process where halobacte-
rial strains were created with a unique cysteine in the
N-terminal extracellular domain [54]. The transloca-
tion of this domain across the membrane was then
probed by derivatising the cysteine with AMS that is
membrane impermeant. Almost 80 amino acids were
found to have been synthesised before the cysteine
was translocated, showing that the N terminus in-
serts co-translationally. This could suggest that co-
translational insertion and folding of the N-terminal,
A helix aids folding of the remaining helices. This is
also consistent with the results from the in vitro fold-
ing and fragment work where the A and B helices
seem to facilitate folding of the remainder of the
protein. The authors point out that the results are
consistent with the membrane insertion being either
spontaneous or mediated by a signal recognition par-
ticle. Halobacteria appear to contain a signal recog-
nition-like particle that may be involved in transla-
tion and insertion of membrane-associated proteins
[55].
6. E¡ect of the lipid environment
The lipid environment is known to a¡ect bR fold-
ing and functionality. Fairly subtle e¡ects of a func-
tional bR, but with altered dynamics, have been ob-
served following solubilisation by di¡erent detergents
or by dehydration of the PM [56^58]. The latter will
alter the lipid phase properties as well as internally
bound water within bR. Despite the role of the lipids
in such ¢ne tuning of function, and presumably also
the ¢nal structure of the folded state, bR can refold
and function in a number of non-native-like lipids
and detergents, and thus is rather insensitive to the
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exact nature of the refolding environment as long as
certain criteria are met. It should, however, be noted
that although the delipidated protein used in the re-
folding work contains 6 5% native lipids, or 6 1
lipid per bR monomer, there may be some bR mono-
mers that are stabilised by the binding of a native
lipid. Recent crystal structures of bR have reported
native lipids bound to the protein [19,38,59]. The
organic phase extraction method used to delipidate
the protein [12] in the refolding work probably re-
moves more of the native lipids than the detergent
solubisation in the crystallographic studies.
A factor that seems likely to be important for
folding membrane proteins is a good match between
the hydrophobic thickness of the protein and lipid
bilayer, although it appears this does not have to
be tightly controlled for bR. bR appears to be able
to fold and function in lipid bilayers with C12^18
hydrocarbon chains and hydrophobic thicknesses
that are probably within a few angstroms of that
of bR. Reconstitution of PM into these C12^18
phosphatidylcholine (PC) lipid bilayers show that
the surrounding alkyl chains are elongated or com-
pressed when their hydrophobic thickness is less than
or greater than that of bR, respectively [60]. Certain
native lipids remained bound to the protein in this
study and their e¡ect on the protein was not inves-
tigated. SDS-denatured bO is also able to refold to
about 100% yield in PC bilayer vesicles with C14^
C18 chains [26].
A lipid property that also seems to be important
for the folding, stability and function of bR is the
curvature elastic energy within the bilayer. This has
been shown in a variety of lipid mixtures containing
phosphatidylcholine (PC) and phosphatidylethanol-
amine (PE) lipids with the same chain length, or
PC lipids with chains of similar length, but di¡erent
degrees of saturation. In these two lipid mixtures, the
introduction of the PE lipid in the former, or the
unsaturated lipid chain in the latter, imparts an in-
creased desire for monolayer curvature towards the
water (see Fig. 3). Since the monolayers are con-
strained £at in the bilayer, this increases the stored
curvature elastic energy within the bilayer [61^63].
One e¡ect of this is to increase the number of colli-
sions between the lipid chains within the bilayer,
which increases the pressure these chains exert on
the refolding protein. Several e¡ects of this increased
chains pressure have been observed for bR. Firstly, it
appears to slow the rate-limiting folding step (i.e.
formation of I2) [25] (P.J. Booth, A.R. Curran,
R.H. Templer, unpublished data). In terms of the
model proposed in Fig. 1, this can be explained by
the increase in the chain pressure hindering the in-
sertion and formation of the F and G helices. A
second e¡ect of this increased lipid chain pressure
is that once a certain pressure is reached, the yield
of refolded protein decreases [26]. This is probably a
combination of the fact that the rate-limiting step is
slowed (possibly allowing other events to compete
with folding) and that once the bilayer gets too rigid,
it becomes harder for the SDS denatured bO to in-
sert into it. The increased pressure also a¡ects the
folded state stability. Increasing the pressure the lipid
chains exert on the helical bundle increase the tem-
perature at which the refolded monomeric bR dena-
tures (W. Meijberg, R.H. Templer, P.J. Booth, un-
published data).
7. Conclusions and future directions
Investigations on bR seem likely to continue to
lead the way in detailed molecular level study of
the folding of K-helical membrane proteins for
some years to come. The large body of structural,
functional and dynamic data as well as the ability
to perform biophysical studies on aspects of the fold-
ing of bR in vivo and in vitro, place bR in a unique
Fig. 3. The inherent desire for monolayer curvature in bilayers
of biological lipids. Most biologically relevant lipids form
monolayers that wish to bend towards water. The desire for
curvature in monolayers of PC lipids with saturated chains is
increased by the introduction of either PE lipids or PC lipids
with unsaturated chains. However, since the monolayers are
back to back in the bilayer, they cannot bend and are forced to
lie £at. As a result the curvature elastic energy of the bilayer in-
creases.
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position amongst integral membrane proteins. This
holds much promise for molecular level information
on the folding of this protein. The robustness of bR
also makes it an ideal testing ground for developing
techniques to study membrane protein folding that
can then be adapted for other membrane proteins.
The information that currently exists on bR folding
already far exceeds that of any other membrane pro-
tein, except possibly outer membrane L-barrel pro-
teins. However, despite this, many central questions
remain to be addressed. Areas that merit particular
attention are to further the development of ap-
proaches to probe the dynamics and structural
changes of both the protein and surrounding mem-
brane environment during folding in vitro as well as
during certain biogenesis events in vivo.
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